Medicines Discovery Catapult (MDC) announced the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life science innovators.
The rapid expansion of the virtual network to over 330 clinical sites and 1.5 million banked biosamples increases the scale, range, and types of clinical samples available to UK innovators in drug discovery and diagnostics .
Read More: Medicines Discovery Catapult creates a worldwide virtual biobank - OpenSpecimen